Immunoglobulin, anti-(human CD19 antigen) (human-Mus musculus monoclonal MOR00208 heavy chain), disulfide with human-Mus musculus monoclonal MOR00208 κ-chain, dimer (ACI)

Nisoxetine

Guselkumab

6-Chloro-7-[(2R)-2-[[(3-chloro-4-methoxy-2-pyridinyl)oxy]methyl]-1-pyrrolidinyl]-1-[6-[3-(dimethylamino)-1-azetidinyl]-3-pyridinyl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid (ACI)

α-[(9R)-6-Hydroxy-6-oxido-1,12-dioxo-9-[(1-oxooctadecyl)oxy]-5,7,11-trioxa-2-aza-6-phosphanonacos-1-yl]-ω-[3-[[5-[(2,5-dioxo-1-pyrrolidinyl)oxy]-1,5-dioxopentyl]amino]propoxy]poly(oxy-1,2-ethanediyl) sodium salt (1:1) (ACI)

L-Alanyl-L-valyl-L-seryl-L-α-glutamyl-L-isoleucyl-L-glutaminyl-L-phenylalanyl-L-methionyl-L-histidyl-L-asparaginyl-L-leucylglycyl-L-lysyl-L-histidyl-L-leucyl-L-seryl-L-seryl-L-methionyl-L-α-glutamyl-L-arginyl-L-valyl-L-α-glutamyl-L-tryptophyl-L-leucyl-L-arginyl-L-lysyl-L-lysyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-valyl-L-histidyl-L-asparaginyl-L-phenylalanine (ACI)

Immunoglobulin G1, anti-(mucin MUC1) (human-Mus musculus monoclonal PankoMab-GEX heavy chain), disulfide with human-Mus musculus monoclonal PankoMab-GEX light chain, dimer (ACI)

Flanvotumab

Concizumab

Namilumab

Clazakizumab

Thiocol

1-Methyl-2-(6Z,9Z)-6,9-pentadecadien-1-yl-4(1H)-quinolinone (ACI)

(2S)-2-[3-(β-D-Glucopyranosyloxy)-4,5-dihydroxyphenyl]-2,3-dihydro-5,7-dihydroxy-4H-1-benzopyran-4-one (ACI)

Tectorigenin 7-O-xylosylglucoside

6′′-O-Acetylglycitin

Hypocrellin A

Methylophiopogonanone A

3-O-Methylquercetin

3,5,7-Trimethoxyflavone